Synapse - Larry Norton

Results (183)

Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer

Meeting Abstract

Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases

Meeting Abstract

Morikawa, A.; Pentsova, E.; Kemeny, M.; Patil, S.; Li, B. T.; Tang, K.; Fleisher, M.; Van Poznak, C. H.; Norton, L.; Seidman, A. D.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase II study of paclitaxel and dasatinib in metastatic breast cancer

Journal Article

Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer

Journal Article

Chen, F.; Ma, K.; Madajewski, B.; Zhuang, L.; Zhang, L.; Rickert, K.; Marelli, M.; Yoo, B.; Turker, M. Z.; Overholtzer, M.; more...
Nature Communications (2018)

Fulltext@MSK | Save

The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers

Journal Article

Weigelt, B.; Bi, R.; Kumar, R.; Blecua, P.; Mandelker, D. L.; Geyer, F. C.; Pareja, F.; James, P. A.; for the kConFab Investigators; Couch, F. J.; more...
JNCI: Journal of the National Cancer Institute (2018)

Fulltext@MSK | Save

The genomic landscape of endocrine-resistant advanced breast cancers

Journal Article

Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
Cancer Cell (2018)

Fulltext@MSK | Save

Bi-allelic alterations in homologous recombination (HR) DNA repair-related genes as the basis for HR defects in human cancers: A pan-cancer genomics and functional analysis

Meeting Abstract

Riaz, N.; Blecua, P.; Lim, R. S.; Shen, R.; Higginson, D. S.; Weinhold, N.; Norton, L.; Weigelt, B.; Powell, S. N.; Reis-Filho, J. S.
Cancer Research (2018)

Fulltext@MSK | Save

Monosomy 17 in potentially curable HER2-amplified breast cancer: Prognostic and predictive impact

Journal Article

Page, D. B.; Wen, H.; Brogi, E.; Dure, D.; Ross, D.; Spinelli, K. J.; Patil, S.; Norton, L.; Hudis, C.; McArthur, H. L.
Breast Cancer Research and Treatment (2018)

Fulltext@MSK | Save

Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer

Meeting Abstract

Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes

Journal Article

Riaz, N.; Blecua, P.; Lim, R. S.; Shen, R.; Higginson, D. S.; Weinhold, N.; Norton, L.; Weigelt, B.; Powell, S. N.; Reis-Filho, J. S.
Nature Communications (2017)

Fulltext@MSK | Save